1. Achieving Self Reliance in Vaccine Production in The Islamic World 1st Meeting of Vaccine Manufacturers Group Jeddah, KSA, 25 – 26 June 2014 ISLAMIC DEVELOPMENT BANK

2. Outline of Presentation  IDB Focus on Health  IDB Flagship Health Programs  Achieving Self Reliance in Vaccine Production in the Islamic World  Pre-requisite for IDB Support

3. IDB Focus in Health Total Financing from 1976 to 2014: US$2.255 billion Focus in Health – Health system strengthening with focus on maternal, neo natal and child health – Fighting major global pandemics ( Malaria, Polio, Cancer, Cardiovascular…) – Social protection (e.g. social health insurance, Community health Insurance, etc.). Innovative Financing for Health interventions – Triple win initiative (Polio in Pakistan with BMGF)

4. Flagship Programs Quick-win Malaria Control Program PMTCT Polio Eradication Achieving Self-Reliance in Vaccine Production in the Islamic World Blindness Eradication Program, and Coalition for the Eliminations of Obstetric Fistula

5. Achieving Self-Reliance in Vaccine Production in the Islamic World Program  Strategic Objective: To achieve self-reliance of the Islamic World in the production of vaccine.  Program Objectives: Enhance cooperation among OIC producers in R&D, Production, Sales and Marketing. Promote institutional, human and technical capacity building of OIC producers. Expand/upgrade existing facilities and improve quality control procedures. Assist producers in obtaining WHO certification.

6. Approval date: Dec. 1999 Total Amount: US$5.6 million Achieving Self-Reliance in Vaccine Production in the Islamic World Program (cnt) ApprovalsAmount 6 Technical Assistance (TA) Grants. 2,011,800 15 Operations: Capacity building events, annual meetings and expert recruitment. 1,020,762 Total3,032,562

7. Pre-requisites for Modality of IDB Financing Official request from IDB Governor Feasibility study/detailed project document Part of the country development plan/MCPS

8. Way Forward Using the SRVP Program facility to Enhance Cooperation between MCs through Exploring the possibility of initiating Reverse Linkage in Vaccine Production, Submit Specific Request to IDB to address the development needs of Vaccine producers

9. THANK YOU